Professor Christopher Layton
Consultant Ophthalmic Surgeon
B.APP.SC (HONS), MBBS (HONS), D.PHIL (OXFORD), FRANZCO
Professor Christopher Layton is a private Clinical Ophthalmologist, a national leader in innovative ophthalmology and has a special interest in clinical education. His expertise is in macular disease, lens surgery and minimally invasive glaucoma interventions.
He completed optometry at QUT, ophthalmology in Queensland, Oxford and London, subspecialty training in retinal disease at the Royal Brisbane Hospital and holds a PhD in diabetic retinopathy from Oxford University.
Professor Layton is a Rhodes Scholar and founding director of the LVF Ophthalmology Research Centre. He is also CEO of Ocugene, a Queensland based biotech start-up which is commercialising his gene therapy discoveries targeting macular degeneration, uveitis and choroidal melanoma.
Professor Layton’s work has been widely published in the international literature and has been recognised by multiple international awards.